Retour aux projets

18117.1 PFLS-LS

STR001 as a Novel Treatment for Hearing Loss

Résumé

STR001 as a Novel Treatment for Hearing Loss

Textes supplémentaires

Abstract

STR001 is a drug that Strekin aims to develop for the treatment of hearing loss. Damage to sensory hair cells in the inner ear is a primary cause of sensorineural hearing loss. The proposed drug has been shown to activate a target that favorably affects pathways implicated in hearing health. In this project, we conduct translational preclinical research of STR001 to enable fast entry into clinical development and value creation.

Participants

Alexander Bausch

Wirtschaftspartner

alexander.bausch@strekin.com

Strekin AG Alexander Bausch Hochbergerstrasse 60C 4057 Basel BS CH

Daniel Bodmer

Kontaktperson

daniel.bodmer@usb.ch

Universitätsspital Basel Daniel Bodmer Hebelstrasse 20 4031 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-02-29
Date de fin
2019-11-30
Coûts totaux approuvés
CHF 542745.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%